ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,671.40
0.56%
S&P ASX All Technology
3,013.20
-0.10%
Brent Oil
83.025
-0.12%
US Dollar vs AUD
1.51135
-0.10%
Bitcoin
63,730.85
-0.42%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Standard BioTools Inc (LAB)

  7. Standard BioTools Inc (LAB) News

LAB

Standard BioTools (LAB)

Standard BioTools Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LAB
DateTimeSourceHeadlineSymbolCompany
25/04/202422:01GlobeNewswire Inc.Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthNASDAQ:LABStandard BioTools Inc
25/04/202422:00GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024NASDAQ:LABStandard BioTools Inc
08/04/202422:00GlobeNewswire Inc.Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue ImagingNASDAQ:LABStandard BioTools Inc
04/04/202407:01GlobeNewswire Inc.Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine ResearchNASDAQ:LABStandard BioTools Inc
18/03/202423:12GlobeNewswire Inc.Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common StockNASDAQ:LABStandard BioTools Inc
07/03/202411:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
29/02/202408:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
29/02/202408:01GlobeNewswire Inc.Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LABStandard BioTools Inc
27/02/202408:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LABStandard BioTools Inc
27/02/202400:00GlobeNewswire Inc.Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen SequencingNASDAQ:LABStandard BioTools Inc
23/02/202409:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
23/02/202408:05GlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
15/02/202407:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LABStandard BioTools Inc
15/02/202400:30GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:LABStandard BioTools Inc
08/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LABStandard BioTools Inc
08/02/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LABStandard BioTools Inc
08/02/202400:30GlobeNewswire Inc.Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized MedicineNASDAQ:LABStandard BioTools Inc
03/02/202408:49Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:LABStandard BioTools Inc
20/01/202409:07Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LABStandard BioTools Inc
20/01/202409:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LABStandard BioTools Inc
20/01/202409:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LABStandard BioTools Inc
20/01/202408:48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LABStandard BioTools Inc
20/01/202408:33Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:LABStandard BioTools Inc
13/01/202406:04Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:LABStandard BioTools Inc
10/01/202412:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
10/01/202410:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
10/01/202410:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
10/01/202410:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
10/01/202410:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
10/01/202410:04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
 Showing the most relevant articles for your search:NASDAQ:LAB

Your Recent History

CCOM
SILVER
SILVER
ASX
TLS
Telstra
ASX
XAO
Australian SE All Ordina...
ASX
ORG
Origin Energy
ASX
CBA
Commonwealth Bank Of Aus...
ASX
QBE
QBE Insurance
ASX
XJO
S&P ASX 200
NASDAQ
AAPL
Apple
ASX
ANZ
Australia And New Zealan...
ASX
NAB
National Australia Bank
ASX
WDC
Westfield
FX
AUDCAD
AUD vs CAD
NYSE
JPM
JP Morgan Chase
FX
AUDJPY
AUD vs Yen
ASX
MQG
Macquarie
ASX
XFL
S&P ASX 50
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved